MedPath

Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Double-Blind Treatment of Major Depressive Disorder With Vilazodone

Phase 2
Completed
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2012-12-05
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
79
Registration Number
NCT01742832
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Network Supported Engagement In HIV Care

Not Applicable
Completed
Conditions
HIV
Patient Acceptance of Health Care
Interventions
Other: Supportive Care
First Posted Date
2012-11-15
Last Posted Date
2017-01-20
Lead Sponsor
University of Chicago
Target Recruit Count
105
Registration Number
NCT01726712
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Effect of Nasaleze on Nasal Challenge With Allergen

Not Applicable
Terminated
Conditions
Allergic Rhinitis
Interventions
Drug: Nasaleze Spray
Other: Placebo spray
Biological: Allergen
First Posted Date
2012-11-07
Last Posted Date
2017-01-02
Lead Sponsor
University of Chicago
Target Recruit Count
14
Registration Number
NCT01723397
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Drug Effects on Preference and Reward

Completed
Conditions
Drug Addiction
Interventions
Behavioral: Pairing condition
First Posted Date
2012-11-06
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
103
Registration Number
NCT01722006
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer

Completed
Conditions
Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate
Mucinous Ductal Breast Carcinoma
Central Nervous System Metastases
Invasive Ductal Breast Carcinoma
Recurrent Breast Cancer
Invasive Lobular Breast Carcinoma With Predominant in Situ Component
Lobular Breast Carcinoma in Situ
Papillary Ductal Breast Carcinoma
Invasive Ductal Breast Carcinoma With Predominant Intraductal Component
Invasive Lobular Breast Carcinoma
Interventions
Radiation: hyperfractionated radiation therapy
Other: laboratory biomarker analysis
Radiation: stereotactic radiosurgery
First Posted Date
2012-10-15
Last Posted Date
2024-07-31
Lead Sponsor
University of Chicago
Target Recruit Count
4
Registration Number
NCT01706432
Locations
🇺🇸

University of Chicago, North Chicago, Illinois, United States

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Phase 1
Terminated
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
Other: pharmacological study
Other: laboratory biomarker analysis
Other: pharmacogenomic studies
First Posted Date
2012-10-12
Last Posted Date
2018-05-30
Lead Sponsor
University of Chicago
Target Recruit Count
21
Registration Number
NCT01705106
Locations
🇺🇸

University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

The Effects of Vertical Position on Gas Exchange in Patients With Respiratory Failure

Not Applicable
Active, not recruiting
Conditions
Respiratory Failure
Interventions
Other: Standing
First Posted Date
2012-10-12
Last Posted Date
2025-03-07
Lead Sponsor
University of Chicago
Target Recruit Count
16
Registration Number
NCT01705119
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck
First Posted Date
2012-09-26
Last Posted Date
2024-01-29
Lead Sponsor
University of Chicago
Target Recruit Count
44
Registration Number
NCT01693718
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Outcome of BCF Access in Hemodialysis Patients

Active, not recruiting
Conditions
Dialysis
End Stage Renal Disease (ESRD)
Cephalic Arch Stenosis (CAS)
Brachiocephalic Fistula (BCF)
Interventions
Other: brachiocephalic fistula (BCF)
First Posted Date
2012-09-26
Last Posted Date
2025-03-12
Lead Sponsor
University of Chicago
Target Recruit Count
96
Registration Number
NCT01693263
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

SIMpill Medication Dispensing Device in the Treatment of HCV

Withdrawn
Conditions
Chronic Hepatitis C Virus
Interventions
Device: SIMpill device
First Posted Date
2012-09-24
Last Posted Date
2014-10-08
Lead Sponsor
University of Chicago
Registration Number
NCT01691235
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath